Aktien Sensor

Merck KGaA exceeded its targets in 2024 and is poised for continued growth in 2025, driven by strong demand for its life science and semiconductor products.

Merck’s stock price has risen amid acquisition rumors, but concerns about the company’s ability to compete and meet growth expectations have been fueled by a Morgan Stanley downgrade and Sartorius’ strong recovery.